BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Victorson DE, Choi S, Judson MA, Cella D. Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis. Qual Life Res 2014;23:1301-13. [PMID: 24214179 DOI: 10.1007/s11136-013-0567-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Currie BM, Davies EW, Beaudet A, Stassek L, Kleinman L, Baughman RP. Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with sarcoidosis-associated pulmonary hypertension (SAPH): a qualitative interview study. BMC Pulm Med 2021;21:365. [PMID: 34772372 DOI: 10.1186/s12890-021-01694-1] [Reference Citation Analysis]
2 Judson MA, Chaudhry H, Louis A, Lee K, Yucel R. The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis. Respir Med 2015;109:526-31. [PMID: 25698652 DOI: 10.1016/j.rmed.2015.01.019] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 8.7] [Reference Citation Analysis]
3 Judson MA. Quality of Life Assessment in Sarcoidosis. Clin Chest Med 2015;36:739-50. [PMID: 26593146 DOI: 10.1016/j.ccm.2015.08.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
4 Wijsenbeek MS, Culver DA. Treatment of Sarcoidosis. Clin Chest Med 2015;36:751-67. [PMID: 26593147 DOI: 10.1016/j.ccm.2015.08.015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
5 Wanat KA, Rosenbach M. A practical approach to cutaneous sarcoidosis. Am J Clin Dermatol 2014;15:283-97. [PMID: 24820822 DOI: 10.1007/s40257-014-0079-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
6 Pande A, Culver DA. Knowing when to use steroids, immunosuppressants or biologics for the treatment of sarcoidosis. Expert Rev Respir Med 2020;14:285-98. [PMID: 31868547 DOI: 10.1080/17476348.2020.1707672] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
7 Judson MA. The Clinical Features of Sarcoidosis: A Comprehensive Review. Clin Rev Allergy Immunol. 2015;49:63-78. [PMID: 25274450 DOI: 10.1007/s12016-014-8450-y] [Cited by in Crossref: 87] [Cited by in F6Publishing: 68] [Article Influence: 14.5] [Reference Citation Analysis]
8 Korenromp IH, Laar MAVD. Health-related quality of life in sarcoidosis: . Current Opinion in Pulmonary Medicine 2014;20:503-7. [DOI: 10.1097/mcp.0000000000000079] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
9 Judson MA, Mack M, Beaumont JL, Watt R, Barnathan ES, Victorson DE. Validation and important differences for the Sarcoidosis Assessment Tool. A new patient-reported outcome measure. Am J Respir Crit Care Med 2015;191:786-95. [PMID: 25594886 DOI: 10.1164/rccm.201410-1785OC] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 3.9] [Reference Citation Analysis]
10 Salsman JM, Park CL, Hahn EA, Snyder MA, George LS, Steger MF, Merluzzi T, Cella D. Refining and supplementing candidate measures of psychological well-being for the NIH PROMIS®: qualitative results from a mixed cancer sample. Qual Life Res 2018;27:2471-6. [PMID: 29926344 DOI: 10.1007/s11136-018-1896-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Wanat KA, Rosenbach M. Cutaneous Sarcoidosis. Clinics in Chest Medicine 2015;36:685-702. [DOI: 10.1016/j.ccm.2015.08.010] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 6.4] [Reference Citation Analysis]
12 Obi ON. Health-Related Quality of Life in Sarcoidosis. Semin Respir Crit Care Med 2020;41:716-32. [PMID: 32583381 DOI: 10.1055/s-0040-1710080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]